{"id":"https://openalex.org/W2985490297","doi":"https://doi.org/10.1182/blood-2019-130722","title":"Abnl Marro: An International Cooperative Trial for Patients with MDS/MPN Overlap Syndromes","display_name":"Abnl Marro: An International Cooperative Trial for Patients with MDS/MPN Overlap Syndromes","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2985490297","doi":"https://doi.org/10.1182/blood-2019-130722","mag":"2985490297"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-130722","doi":"https://doi.org/10.1182/blood-2019-130722","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-130722","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Department of Medicine and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014838075","display_name":"Pierre Fenaux","orcid":"https://orcid.org/0000-0002-0468-3553","observed_orcids":["https://orcid.org/0000-0002-0468-3553"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Fenaux","raw_affiliation_strings":["H\u00f4pital St Louis/Universit\u00e9 Paris 7 / Service d'h\u00e9matologie s\u00e9niors, H\u00f4pital Saint-Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital St Louis/Universit\u00e9 Paris 7 / Service d'h\u00e9matologie s\u00e9niors, H\u00f4pital Saint-Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041754278","display_name":"Eric Padron","orcid":"https://orcid.org/0000-0002-4707-7916","observed_orcids":["https://orcid.org/0000-0002-4707-7916"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Padron","raw_affiliation_strings":["Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M Patnaik","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079124367","display_name":"Uwe Platzbecker","orcid":"https://orcid.org/0000-0003-1863-3239","observed_orcids":["https://orcid.org/0000-0003-1863-3239"]},"institutions":[{"id":"https://openalex.org/I4210125843","display_name":"University Hospital Leipzig","ror":"https://ror.org/028hv5492","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210125843"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe Platzbecker","raw_affiliation_strings":["Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany","institution_ids":["https://openalex.org/I4210125843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002404022","display_name":"Adam C. Seegmiller","orcid":"https://orcid.org/0000-0003-2832-2039","observed_orcids":["https://orcid.org/0000-0003-2832-2039"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Seegmiller","raw_affiliation_strings":["Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004876764","display_name":"Rapha\u00ebl Itzykson","orcid":"https://orcid.org/0000-0003-2139-6262","observed_orcids":["https://orcid.org/0000-0003-2139-6262"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4405261462","display_name":"Laboratoire d'h\u00e9matologie","ror":"https://ror.org/05b9w4n89","country_code":"FR","type":"facility","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4405261462"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Raphael Itzykson","raw_affiliation_strings":["H\u00e9matologie clinique, H\u00f4pital Saint-Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00e9matologie clinique, H\u00f4pital Saint-Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610","https://openalex.org/I4405261462"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052934298","display_name":"Guillermo Francisco Sanz","orcid":"https://orcid.org/0000-0002-2767-8191","observed_orcids":["https://orcid.org/0000-0002-2767-8191"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Guillermo F. Sanz","raw_affiliation_strings":["Dept. of Hematology, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Hematology, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091318797","display_name":"Valeria Santini","orcid":"https://orcid.org/0000-0002-5439-2172","observed_orcids":["https://orcid.org/0000-0002-5439-2172"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]},{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valeria Santini","raw_affiliation_strings":["MDS Unit, Azienda Ospedaliero Universitaria (AOU) Careggi, University of Florence, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MDS Unit, Azienda Ospedaliero Universitaria (AOU) Careggi, University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I4210115393","https://openalex.org/I45084792"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023810956","display_name":"\u00c9ric Solary","orcid":"https://orcid.org/0000-0002-8629-1341","observed_orcids":["https://orcid.org/0000-0002-8629-1341"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eric Solary","raw_affiliation_strings":["Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"4273","last_page":"4273"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-myeloproliferative-neoplasms","display_name":"myelodysplastic/myeloproliferative neoplasms","score":0.9559999704360962},{"id":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia","display_name":"chronic myelomonocytic leukemia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7590000033378601},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cedazuridine","display_name":"cedazuridine","score":0.968999981880188},{"id":"https://openalex.org/keywords/astx727","display_name":"ASTX727","score":0.9670000076293945},{"id":"https://openalex.org/keywords/itacitinib","display_name":"itacitinib","score":0.8930000066757202},{"id":"https://openalex.org/keywords/pim-inhibitors","display_name":"PIM inhibitors","score":0.6420000195503235},{"id":"https://openalex.org/keywords/lsd1-inhibitors","display_name":"LSD1 inhibitors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.7059999704360962},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.753000020980835},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5514182448387146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47029921412467957},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.4685341417789459},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35950204730033875},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.176259845495224}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-130722","doi":"https://doi.org/10.1182/blood-2019-130722","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-130722","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296970967","https://openalex.org/W4389229989","https://openalex.org/W4389243891","https://openalex.org/W2990289955","https://openalex.org/W2987605828","https://openalex.org/W7165168841","https://openalex.org/W2770293018","https://openalex.org/W3093975417","https://openalex.org/W2905521090","https://openalex.org/W2571330258"],"abstract_inverted_index":{"Background:":[0],"Myelodysplastic/myeloproliferative":[1],"neoplasms":[2],"(MDS/MPN)":[3],"in":[4,78,94,164,224,274,281,304,324,329,337,355,485,508,519,573,643,695,1035],"adult":[5],"populations":[6],"include":[7],"several":[8],"rare":[9],"hematologic":[10],"malignancies":[11],"with":[12,60,166,202,326,394,397],"similar":[13],"clinicopathologic":[14],"features":[15],"that":[16,156,271,445,653,673],"have":[17,99],"a":[18,173,179,205,225,241,246,264,285,470,556,585],"significant":[19],"impact":[20],"on":[21,433,701,716,729,742,757,769,783,820,840,853,865,879,896,912,926,939,953,966,977,988,1001,1013],"patient":[22],"QOL":[23],"and":[24,33,41,67,82,90,115,131,137,177,187,214,234,245,258,298,390,406,489,496,503,544,592,608,617,637,681,692],"lead":[25],"to":[26,35,63,76,193,230,289,299,548,633],"increased":[27],"risk":[28,689],"of":[29,49,70,109,168,183,236,248,270,293,307,311,334,344,392,438,498,504,527,558,580,590,594,605,612,630,639,657,678,687,705,720,733,746,761,773,787,824,844,857,869,883,900,916,930,943,957,970,981,992,1005,1017],"infection,":[30],"hemorrhage,":[31],"anemia":[32],"transformation":[34],"AML":[36],"(e.g.":[37],"CMML,":[38],"aCML,":[39],"MDS/MPN-RST,":[40],"MDS/MPN-U).":[42],"The":[43,139,198,369,560,603],"only":[44,384],"approved":[45],"therapies":[46],"for":[47,57,112,126,129,263,415,423,428,534,555,664],"any":[48,294,613],"the":[50,65,68,124,184,188,232,256,312,327,372,421,424,442,446,450,474,494,499,509,524,529,577,597,627,631,635,645,649,655,658,684],"MDS/MPNs":[51],"are":[52,339,409,431,514,571],"DNA":[53],"methyltransferase":[54],"inhibitors":[55],"(DNMTis)":[56],"patients":[58],"(pts)":[59],"CMML.":[61],"Due":[62],"both":[64,541],"rarity":[66],"heterogeneity":[69],"MDS/MPNs,":[71,165],"it":[72],"has":[73,87,260,316],"been":[74,88,102,261],"challenging":[75],"study":[77,108,141,155,378,632,646],"dedicated,":[79],"prospective":[80,666],"studies":[81,343],"thus":[83],"refining":[84],"treatment":[85,162,170,296,396,492,641],"strategies":[86],"difficult":[89],"optimal":[91],"salvage":[92],"treatments":[93],"pts":[95,276,393,416,481,522,539,575],"who":[96],"fail":[97],"DNMTis":[98],"also":[100],"not":[101,340],"rigorously":[103],"studied.":[104],"ABNL-MARRO":[105],"(A":[106],"Basket":[107],"Novel":[110],"therapy":[111,239,273],"untreated":[113],"MDS/MPN":[114,275,338,418,451,659,1036],"Relapsed/Refractory":[116],"Overlap":[117],"Syndromes)":[118],"is":[119,148,319,464,601,615],"an":[120,149,702,717,730,743,758,770,784,821,841,854,866,880,897,913,927,940,954,967,978,989,1002,1014],"international":[121,660],"cooperation":[122],"providing":[123],"framework":[125],"clinical":[127,411,685],"trials":[128],"MDS/MPN,":[130,644],"explore":[132],"clinical-pathologic":[133],"biomarkers.":[134],"Study":[135],"Design":[136],"Methods:":[138],"first":[140,223,475],"within":[142],"ABNL-MARRO,":[143],"ABNL":[144,650],"MARRO":[145,651],"001":[146],"(AM-001),":[147],"open":[150],"label,":[151],"randomized":[152],"phase":[153,282,376,510],"1-2":[154],"will":[157,220,252,277,466,482,490,531,552,563,647,668,674,682],"test":[158],"3":[159,169],"novel":[160,174,199,266,500,640],"oral":[161,196],"combinations":[163,303,642],"each":[167,237,310,429,486],"arms":[171],"including":[172],"targeted":[175,313,501],"agent":[176,375,502],"ASTX727,":[178,505,1028],"fixed":[180],"dose":[181,250],"combination":[182,219,238,272,325],"DNMTi":[185,328],"decitabine":[186,195],"cytidine":[189],"deaminase":[190],"inhibitor":[191,208,212],"cedazuridine":[192],"improve":[194,675],"bioavailability.":[197],"agents":[200,314],"combined":[201,459],"ASTX727":[203,373],"are:":[204],"selective":[206],"JAK1":[207,1033],"itacitinib,":[209],"pan":[210],"PIM":[211,1031],"INCB053914":[213],"LSD1":[215,1029],"inhibitor,":[216],"INCB059872.":[217],"Each":[218],"be":[221,253,279,467,483,532,553,564],"tested":[222,468],"safety":[226,322,636],"run-in":[227],"(Phase":[228],"1b)":[229],"determine":[231],"RP2D":[233,257,495],"schedule":[235,259,497],"using":[240,284],"3+3":[242],"de-escalation":[243],"design,":[244],"maximum":[247],"four":[249],"decrements":[251],"allowed.":[254],"After":[255],"determined":[262,507],"given":[265],"drug":[267],"combination,":[268],"efficacy":[269,625,638],"then":[278],"evaluated":[280],"2":[283],"Simon's":[286,425],"Two-Stage":[287,426],"design":[288,427,583],"allow":[290],"early":[291,606],"discontinuation":[292],"futile":[295],"regimen":[297],"pursue":[300],"potentially":[301],"beneficial":[302],"larger":[305],"cohorts":[306],"pts.":[308],"While":[309],"either":[315],"undergone":[317],"or":[318,346,399,516,568,707,722,735,748,763,775,789,826,846,859,871,885,902,918,932,945,959,972,983,994,1007,1019],"currently":[320],"undergoing":[321],"testing":[323],"myeloid":[330],"diseases,":[331],"clear":[332],"rates":[333,351],"expected":[335,609],"responses":[336,518,570],"known.":[341],"Retrospective":[342],"DAC":[345,400],"AZA":[347,398],"reveal":[348],"overall":[349],"response":[350,599,693],"(ORR)":[352],"from":[353,371,436],"10-56%":[354],"CMML":[356,386],"(Helbig":[357],"et":[358,362,366,402,456],"al,":[359,363,367,403,457],"2019;":[360],"Duchman":[361],"2018;":[364],"Coston":[365],"2019).":[368,404],"ORR":[370],"single":[374],"I":[377,587],"was":[379],"30%,":[380],"but":[381],"this":[382],"included":[383],"14%":[385],"(remainder":[387],"MDS":[388],"pts)":[389],"45%":[391],"previous":[395],"(Savona":[401,455],"Finally,":[405],"importantly,":[407],"there":[408,513],"insufficient":[410],"trial":[412],"data":[413],"available":[414],"non-CMML":[417],"syndromes.":[419],"Thus,":[420],"criteria":[422],"arm":[430,614],"based":[432],"best":[434],"estimation":[435],"results":[437],"above":[439],"studies.":[440],"Accordingly,":[441],"null":[443,561],"hypothesis":[444,562],"ORR,":[447],"as":[448,506],"per":[449],"Proposed":[452],"Response":[453],"Criteria":[454],"2015;":[458],"CR+MR+PR+Clinical":[460],"benefit":[461],"-":[462,891,908],"CB),":[463],"35%,":[465],"against":[469],"one-sided":[471],"alternative.":[472],"In":[473],"stage,":[476],"14":[477,521],"DNMTI-treatment":[478],"na\u00efve":[479],"(TN)":[480],"accrued":[484,554],"AM-001":[487],"Arm":[488,530],"receive":[491],"at":[493],"1.":[511],"If":[512],"5":[515],"fewer":[517],"these":[520],"before":[523,576],"7th":[525,578],"cycle":[526,579],"therapy,":[528],"stopped":[533],"futility.":[535],"Otherwise,":[536],"30":[537],"additional":[538],"(including":[540],"TN":[542],"subjects":[543,545],"relapsed":[546],"after/refractory":[547],"other":[549],"DNMTI-containing":[550],"therapies)":[551],"total":[557],"44.":[559],"rejected":[565],"if":[566],"21":[567],"more":[569],"observed":[572],"44":[574],"therapy.":[581],"This":[582],"yields":[584],"type":[586],"error":[588],"rate":[589,600],"0.05":[591],"power":[593],"80%":[595],"when":[596],"true":[598],"55%.":[602],"probability":[604],"termination":[607],"sample":[610],"size":[611],"64%":[616],"25":[618],"pts,":[619],"respectively,":[620],"assuming":[621],"low":[622],"(35%":[623],"RR)":[624],"Beyond":[626],"primary":[628],"objectives":[629],"evaluate":[634],"establish":[648],"infrastructure":[652],"leverages":[654],"expertise":[656],"working":[661],"group":[662],"(IWG)":[663],"future":[665],"studies;":[667],"forge":[669],"innovative":[670],"scientific":[671],"research":[672],"our":[676],"understanding":[677],"pathogenetic":[679],"etiologies;":[680],"inform":[683],"application":[686],"diagnosis,":[688],"stratification":[690],"tools,":[691],"assessments":[694],"MDS/MPNs.":[696],"Disclosures":[697],"Savona:":[698],"AbbVie:":[699,950],"Membership":[700,715,728,741,756,768,782,819,839,852,864,878,895,911,925,938,952,965,976,987,1000,1012],"entity's":[703,718,731,744,759,771,785,822,842,855,867,881,898,914,928,941,955,968,979,990,1003,1015],"Board":[704,719,732,745,760,772,786,823,843,856,868,882,899,915,929,942,956,969,980,991,1004,1016],"Directors":[706,721,734,747,762,774,788,825,845,858,870,884,901,917,931,944,958,971,982,993,1006,1018],"advisory":[708,723,736,749,764,776,790,827,847,860,872,886,903,919,933,946,960,973,984,995,1008,1020],"committees;":[709,750,765,791,861,974,985,996,1009,1021],"Sunesis:":[710],"Research":[711,725,738,778,798,802,806,811,814,849,874,888,905,921,935,948,962],"Funding;":[712,726,739,779,799,803,807,850,875,889,906,922,936,949],"TG":[713],"Therapeutics:":[714,752],"committees,":[724,737,777,848,873,887,904,920,934,947,961],"Takeda:":[727],"Selvita:":[740],"Karyopharm":[751],"Consultancy,":[753,830,833,836],"Equity":[754],"Ownership,":[755],"Incyte":[766],"Corporation:":[767,781,809,998],"Celgene":[780,808,997],"Boehringer":[792],"Ingelheim:":[793],"Patents":[794],"&":[795,1023],"Royalties.":[796],"Fenaux:Aprea:":[797],"Jazz:":[800],"Honoraria,":[801,805,810,863,894,910,924,951,999,1011],"Astex:":[804],"Funding.":[812,815,963],"Padron:Incyte:":[813],"Patnaik:Stem":[816],"Line":[817],"Pharmaceuticals.:":[818],"committees.":[828],"Platzbecker:Abbvie:":[829],"Honoraria;":[831,834],"Celgene:":[832,862],"Novartis:":[835,923,1010],"Honoraria.":[837,1025],"Sanz:Amgen:":[838],"Boehringer-Ingelheim:":[851],"Helsinn":[876],"Healthcare:":[877],"Hoffman":[890],"La":[892],"Roche:":[893],"Janssen":[907],"Cilag:":[909],"Onconova:":[937],"Santini:Menarini:":[964],"Amgen:":[975],"Acceleron:":[986],"Johnson":[1022],"Johnson:":[1024],"OffLabel":[1026],"Disclosure:":[1027],"inh,":[1030,1032],"inh":[1034]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2019-11-22T00:00:00"}